Cargando…

Resveratrol-Loaded Attalea funifera Oil Organogel Nanoparticles: A Potential Nanocarrier against A375 Human Melanoma Cells

This study aimed to evaluate Attalea funifera seed oil with or without resveratrol entrapped in organogel nanoparticles in vitro against A375 human melanoma tumor cells. Organogel nanoparticles with seed oil (SON) or with resveratrol entrapped in the seed oil (RSON) formed functional organogel nanop...

Descripción completa

Detalles Bibliográficos
Autores principales: Dourado, Douglas, Batista, Fabiana Pacheco Reis, Philadelpho, Biane Oliveira, de Souza, Myla Lôbo, de Cerqueira e Silva, Mariana Barros, de Grandis, Rone Aparecido, Miranda, Priscila Anjos, Colauto, Nelson Barros, Pereira, Daniel T., Formiga, Fabio Rocha, Cilli, Eduardo Maffud, Pavan, Fernando Rogério, Oliveira de Souza, Carolina, Ferreira, Ederlan de Souza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419039/
https://www.ncbi.nlm.nih.gov/pubmed/37569487
http://dx.doi.org/10.3390/ijms241512112
Descripción
Sumario:This study aimed to evaluate Attalea funifera seed oil with or without resveratrol entrapped in organogel nanoparticles in vitro against A375 human melanoma tumor cells. Organogel nanoparticles with seed oil (SON) or with resveratrol entrapped in the seed oil (RSON) formed functional organogel nanoparticles that showed a particle size <100 nm, polydispersity index <0.3, negative zeta potential, and maintenance of electrical conductivity. The resveratrol entrapment efficiency in RSON was 99 ± 1%. The seed oil and SON showed no cytotoxicity against human non-tumor cells or tumor cells. Resveratrol at 50 μg/mL was cytotoxic for non-tumor cells, and was cytotoxic for tumor cells at 25 μg/mL. Resveratrol entrapped in RSON showed a decrease in cytotoxicity against non-tumor cells and cytotoxic against tumor cells at 50 μg/mL. Thus, SON is a potential new platform for the delivery of resveratrol with selective cytotoxic activity in the treatment of melanoma.